2905-26-2 Purity
97%
If you have any other questions or need other size, please get a quote.
Specification
Tajima, Kosuke, et al. Journal of Controlled Release 343 (2022): 434-442.
This study described the use of 8-[Fluo]-cAMP, a fluorescent adenosine-3',5'-cyclic monophosphate derivative, as a functional probe to evaluate organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4) activity at the inner blood-retinal barrier (BRB).
Fresh retinal capillaries were prepared from rat retinae using serial filtration and density-gradient centrifugation without enzymatic digestion or freezing, preserving native capillary structure. Marker expression (for example, facilitative glucose transporter-1 and claudin-5) was confirmed by RT-PCR and immunostaining to verify endothelial and barrier identity. Functional assays employed fluorescent transporter substrates (including 8-[Fluo]-cAMP) to measure luminal accumulation within the intact capillary lumen; changes in accumulation in the presence of known transporter substrates or inhibitors were used to attribute activity to specific transporters.
8-[Fluo]-cAMP was used as a fluorescent probe whose luminal accumulation in freshly isolated retinal capillaries responds to modulation of Oat3 and Mrp4. The study reported that luminal accumulation of 8-[Fluo]-cAMP decreased when Oat3 and Mrp4 substrates/inhibitors were applied, indicating that its translocation across capillary endothelium is mediated, at least in part, by these transporters. In this experimental context, 8-[Fluo]-cAMP functioned as a practical readout of SLC (Oat) and ABC (Mrp) transporter activities at the inner BRB.
Romero, Francisco, et al. FEBS letters 591.18 (2017): 2869-2878.
Characterizing the molecular interactions between cyclic nucleotide-binding domains (CNBDs) and their ligands is fundamental to understanding cellular signaling pathways. This study examined the development and advantages of a fluorescence resonance energy transfer (FRET)-based binding assay utilizing 8-(2-[Fluoresceinyl]aminoethylthio) adenosine-3', 5'-cyclic monophosphate (8-[Fluo]-cAMP) as a key fluorescent probe.
Assay Design: The assay pairs CFP fused to a CNBD (serving as the FRET donor) with 8-[Fluo]-cAMP (the acceptor). Upon ligand binding, close proximity between CFP and the fluorescein label produces efficient FRET that can be measured ratiometrically on standard fluorescence readers.
Performance: The CFP-CNBD / 8-[Fluo]-cAMP FRET pair resulted in ~80% energy transfer, which enabled high detection power for binding events. The high brightness of 8-[Fluo]-cAMP enabled measurements of binding at low (nanoM) concentrations of both ligand and protein with conventional laboratory fluorescence instruments. The CFP fusion allowed specific binding measurements even without full purification of the CNBD, simplifying workflows and lowering material needs.
The molecular formula of 8-[Fluo]-cAMP is C33H27N7O11PS2-.
The molecular weight of 8-[Fluo]-cAMP is 792.7 g/mol.
The parent compound of 8-[Fluo]-cAMP is not mentioned in the reference.
8-[Fluo]-cAMP was created on March 25, 2017.
8-[Fluo]-cAMP was last modified on October 21, 2023.
The IUPAC name of 8-[Fluo]-cAMP is 5-[2-[6-amino-9-(7-hydroxy-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)purin-8-yl]sulfanylethylcarbamothioylamino]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid.
The InChI of 8-[Fluo]-cAMP is InChI=1S/C33H28N7O11PS2/c34-28-25-29(37-13-36-28)40(30-26(43)27-23(50-30)12-48-52(46,47)51-27)33(39-25)54-8-7-35-32(53)38-14-1-4-17(20(9-14)31(44)45)24-18-5-2-15(41)10-21(18)49-22-11-16(42)3-6-19(22)24/h1-6,9-11,13,23,26-27,30,41,43H,7-8,12H2,(H,44,45)(H,46,47)(H2,34,36,37)(H2,35,38,53)/p-1.
The InChIKey of 8-[Fluo]-cAMP is CQCCASCBDPGSNI-UHFFFAOYSA-M.
The canonical SMILES of 8-[Fluo]-cAMP is C1C2C(C(C(O2)N3C4=NC=NC(=C4N=C3SCCNC(=S)NC5=CC(=C(C=C5)C6=C7C=CC(=O)C=C7OC8=C6C=CC(=C8)O)C(=O)O)N)O)OP(=O)(O1)[O-].
8-[Fluo]-cAMP has 6 hydrogen bond donor counts.
Please kindly note that our products are for research use only.
Download